Carlsmed (CARL) Competitors $13.38 +0.64 (+5.02%) As of 09/8/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsSEC FilingsTrendsBuy This Stock CARL vs. SSII, CDRE, BLFS, ESTA, MDXG, PLSE, INMD, IRMD, BBNX, and EMBCShould you be buying Carlsmed stock or one of its competitors? The main competitors of Carlsmed include SS Innovations International (SSII), Cadre (CDRE), BioLife Solutions (BLFS), Establishment Labs (ESTA), MiMedx Group (MDXG), Pulse Biosciences (PLSE), InMode (INMD), iRadimed (IRMD), Beta Bionics (BBNX), and Embecta (EMBC). These companies are all part of the "medical equipment" industry. Carlsmed vs. Its Competitors SS Innovations International Cadre BioLife Solutions Establishment Labs MiMedx Group Pulse Biosciences InMode iRadimed Beta Bionics Embecta SS Innovations International (NASDAQ:SSII) and Carlsmed (NASDAQ:CARL) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, risk, media sentiment, valuation, earnings, analyst recommendations, institutional ownership and profitability. Which has higher earnings and valuation, SSII or CARL? Carlsmed has lower revenue, but higher earnings than SS Innovations International. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSS Innovations International$20.65M57.56-$19.15MN/AN/ACarlsmedN/AN/AN/AN/AN/A Does the media refer more to SSII or CARL? In the previous week, SS Innovations International and SS Innovations International both had 1 articles in the media. SS Innovations International's average media sentiment score of 0.75 beat Carlsmed's score of -1.00 indicating that SS Innovations International is being referred to more favorably in the media. Company Overall Sentiment SS Innovations International Positive Carlsmed Negative Is SSII or CARL more profitable? Carlsmed has a net margin of 0.00% compared to SS Innovations International's net margin of -40.20%. Carlsmed's return on equity of 0.00% beat SS Innovations International's return on equity.Company Net Margins Return on Equity Return on Assets SS Innovations International-40.20% -40.41% -20.80% Carlsmed N/A N/A N/A SummaryCarlsmed beats SS Innovations International on 3 of the 5 factors compared between the two stocks. Get Carlsmed News Delivered to You Automatically Sign up to receive the latest news and ratings for CARL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CARL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CARL vs. The Competition Export to ExcelMetricCarlsmedSurgical, Medical, And Dental Instruments And Supplies IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$338.64M$193.33M$2.53B$9.93BDividend YieldN/AN/A2.52%4.53%P/E RatioN/A2.0526.1626.46Price / SalesN/A30.97103.7487.69Price / CashN/A4.0623.1829.11Price / BookN/A1.6131.856.14Net IncomeN/A-$66.04M$16.40M$265.92M7 Day PerformanceN/A-2.08%1.08%8.05%1 Month PerformanceN/A-2.80%3.23%13.39%1 Year PerformanceN/A152.45%18.13%29.12% Carlsmed Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CARLCarlsmedN/A$13.38+5.0%N/AN/A$338.64MN/A0.00100Negative NewsSSIISS Innovations InternationalN/A$7.00flatN/AN/A$1.36B$20.65M0.004News CoverageGap DownCDRECadre3.265 of 5 stars$31.96+0.2%$31.50-1.4%-5.9%$1.30B$567.56M33.992,284News CoveragePositive NewsBLFSBioLife Solutions2.5058 of 5 stars$26.46+2.3%$31.29+18.2%+10.2%$1.27B$82.25M-220.48440ESTAEstablishment Labs2.664 of 5 stars$39.03+0.9%$56.50+44.8%-8.1%$1.13B$166.02M-12.801,018Positive NewsMDXGMiMedx Group3.3706 of 5 stars$7.14+0.7%$12.00+68.1%+16.6%$1.06B$348.88M34.00870Positive NewsPLSEPulse Biosciences3.9958 of 5 stars$15.11-0.4%$22.00+45.6%-12.5%$1.02B$700K-14.39140News CoveragePositive NewsINMDInMode3.4765 of 5 stars$14.98+4.0%$18.04+20.4%-2.6%$946.89M$394.82M6.06480Positive NewsIRMDiRadimed4.7426 of 5 stars$71.99-0.2%$72.00+0.0%+60.1%$915.71M$73.24M44.44110BBNXBeta BionicsN/A$20.20+0.5%$22.56+11.7%N/A$878.09M$65.12M0.00294News CoverageInsider TradeEMBCEmbecta4.6321 of 5 stars$14.96+3.2%$19.00+27.0%-4.3%$874.94M$1.10B10.462,100Positive News Related Companies and Tools Related Companies SSII Competitors CDRE Competitors BLFS Competitors ESTA Competitors MDXG Competitors PLSE Competitors INMD Competitors IRMD Competitors BBNX Competitors EMBC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CARL) was last updated on 9/9/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredBuffett, Gates and Bezos Dumping StocksThe world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated b...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored2013 Bitcoin miner reveals his trading system (free)While everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Carlsmed, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Carlsmed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
